Correction to: Cancer Gene Therapy https://doi.org/10.1038/s41417-022-00501-1, published online 15 July 2022
In Table 2 of this article, the data in the Table 2 headed Nrf2 overexpression increases cytarabine resistance in acute myeloid leukemia through inhibition of replication factor C4 were mistakenly listed under the table 2.
We have carefully corrected this error, and the corrected Table 2 is as shown above.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hu, T., Pan, C., Zhang, T. et al. Correction: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4. Cancer Gene Ther 29, 1804–1805 (2022). https://doi.org/10.1038/s41417-022-00519-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41417-022-00519-5
